{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:42:25Z","timestamp":1790336545405,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejmech.2023.115853","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T03:12:27Z","timestamp":1696648347000},"page":"115853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Development of teixobactin analogues containing hydrophobic, non-proteogenic amino acids that are highly potent against multidrug-resistant bacteria and biofilms"],"prefix":"10.1016","volume":"261","author":[{"given":"Anish","family":"Parmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamani","family":"Lakshminarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Tze Leng","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Ying","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey Kuok Hoong","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Newire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eefjan","family":"Breukink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Madder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-1063","authenticated-orcid":false,"given":"Ishwar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7535","key":"10.1016\/j.ejmech.2023.115853_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.ejmech.2023.115853_bib2","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1002\/anie.201501440","article-title":"Multiple attack on bacteria by the new antibiotic teixobactin","volume":"54","author":"von Nussbaum","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"10","key":"10.1016\/j.ejmech.2023.115853_bib3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/acsinfecdis.7b00108","article-title":"Teixobactin and its analogues: a new hope in antibiotic discovery","volume":"3","author":"Fiers","year":"2017","journal-title":"ACS Infect. Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115853_bib4","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/acs.orglett.6b01324","article-title":"Total synthesis of teixobactin","volume":"18","author":"Giltrap","year":"2016","journal-title":"Org. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115853_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12394","article-title":"Total synthesis of teixobactin","volume":"7","author":"Jin","year":"2016","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.ejmech.2023.115853_bib6","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1021\/acs.orglett.5b03176","article-title":"Synthesis and biological evaluation of a teixobactin analogue","volume":"17","author":"Jad","year":"2015","journal-title":"Org. Lett."},{"issue":"36","key":"10.1016\/j.ejmech.2023.115853_bib7","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1039\/C5CC10249A","article-title":"Efficient total syntheses and biological activities of two teixobactin analogues","volume":"52","author":"Parmar","year":"2016","journal-title":"Chem. Commun."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115853_bib8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschembio.6b00295","article-title":"Elucidation of the teixobactin pharmacophore","volume":"11","author":"Yang","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115853_bib9","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1039\/C6CC09490B","article-title":"Defining the molecular structure of teixobactin analogues and understanding their role in antibacterial activities","volume":"53","author":"Parmar","year":"2017","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115853_bib10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acsomega.6b00354","article-title":"Lysine scanning of Arg 10 \u2013teixobactin: deciphering the role of hydrophobic and hydrophilic residues","volume":"1","author":"Abdel Monaim","year":"2016","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115853_bib11","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1039\/C6RA26567G","article-title":"Synthesis and structure\u2013activity relationship studies of teixobactin analogues","volume":"7","author":"Wu","year":"2017","journal-title":"RSC Adv."},{"issue":"18","key":"10.1016\/j.ejmech.2023.115853_bib12","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1016\/j.bmc.2017.04.039","article-title":"Synthesis and structure-activity relationship of teixobactin analogues via convergent ser ligation","volume":"25","author":"Jin","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"55","key":"10.1016\/j.ejmech.2023.115853_bib13","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1039\/C7CC04021K","article-title":"Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres","volume":"53","author":"Parmar","year":"2017","journal-title":"Chem. Commun."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115853_bib14","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1039\/C7SC03241B","article-title":"Teixobactin analogues reveal enduracididine to Be non-essential for highly potent antibacterial activity and lipid II binding","volume":"8","author":"Parmar","year":"2017","journal-title":"Chem. Sci."},{"issue":"41","key":"10.1016\/j.ejmech.2023.115853_bib15","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1039\/C7OB02169K","article-title":"Synthesis and biological evaluation of novel teixobactin analogues","volume":"15","author":"Schumacher","year":"2017","journal-title":"Org. Biomol. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2023.115853_bib16","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1039\/C7CC06093A","article-title":"Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus","volume":"54","author":"Girt","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2023.115853_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040183","article-title":"Cysteines and disulfide-bridged macrocyclic mimics of teixobactin analogues and their antibacterial activity evaluation against methicillin-resistant Staphylococcus aureus (MRSA)","author":"Malkawi","year":"2018","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115853_bib18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/acs.jmedchem.7b01634","article-title":"Design and syntheses of highly potent teixobactin analogues against Staphylococcus aureus , methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE) in vitro and in vivo","volume":"61","author":"Parmar","year":"2018","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115853_bib19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bmc.2018.01.016","article-title":"Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine","volume":"26","author":"Jin","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115853_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03009734.2014.896437","article-title":"Discovery and preclinical development of new antibiotics","volume":"119","author":"Hughes","year":"2014","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2023.115853_bib21","article-title":"Membrane active antimicrobial peptides: translating mechanistic insights to design","author":"Li","year":"2017","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115853_bib22","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/s41467-020-16600-2","article-title":"Mode of action of teixobactins in cellular membranes","volume":"11","author":"Shukla","year":"2020","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.ejmech.2023.115853_bib23","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/ja8093247","article-title":"Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity","volume":"131","author":"Rathinakumar","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115853_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18147602","article-title":"Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies","author":"Idrees","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"8","key":"10.1016\/j.ejmech.2023.115853_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1039\/C9MD00044E","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): atibiotic-resistance and the biofilm phenotype","volume":"10","author":"Craft","year":"2019","journal-title":"Med. Chem. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115853_bib26","first-page":"Doc23","article-title":"Clinical characteristics of Staphylococcus epidermidis: a systematic review","volume":"9","author":"Namvar","year":"2014","journal-title":"GMS Hyg Infect Control"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115853_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2958.2003.03493.x","article-title":"SarA and not \u03c3b is eessential for biofilm development by Staphylococcus aureus","volume":"48","author":"Valle","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"15","key":"10.1016\/j.ejmech.2023.115853_bib28","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1128\/JB.187.15.5318-5329.2005","article-title":"Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the ArlRS two-component system","volume":"187","author":"Toledo-Arana","year":"2005","journal-title":"J. Bacteriol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423008206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423008206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:06:06Z","timestamp":1759331166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423008206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"alternative-id":["S0223523423008206"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115853","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of teixobactin analogues containing hydrophobic, non-proteogenic amino acids that are highly potent against multidrug-resistant bacteria and biofilms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115853"}}